Podrobno

The impact of bone marrow involvement on prognosis in diffuse large B-cell lymphoma : an 18F-FDG PET/CT volumetric segmentation study
ID Doma, Andrej (Avtor), ID Studen, Andrej (Avtor), ID Jezeršek Novaković, Barbara (Avtor)

.pdfPDF - Predstavitvena datoteka, prenos (3,38 MB)
MD5: C64A8852408F8D1F78D3DE8296E463D2
URLURL - Izvorni URL, za dostop obiščite https://www.mdpi.com/2072-6694/16/22/3762 Povezava se odpre v novem oknu

Izvleček
Background: This study assessed the prognostic value of tumor burden in bone marrow (BM) and total disease (TD), as depicted on 18F-FDG PET/CT in 140 DLBCL patients, for complete remission after first-line systemic treatment (iCR) and 3- and 5-year overall survival (OS3 and OS5). Methods: Baseline 18F-FDG PET/CT scans of 140 DLBCL patients were segmented to quantify metabolic tumor volume (MTV), total lesion glycolysis (TLG), and SUVmax in BMI, findings elsewhere (XL), and TD. Results: Bone marrow involvement (BMI) presented in 35 (25%) patients. Median follow-up time was 47 months; 79 patients (56%) achieved iCR. iCR was significantly associated with TD MTV, XL MTV, BM PET positivity, and International Prognostic Index (IPI). OS3 was significantly worse with TD MTV, XL MTV, IPI, and age. OS5 was significantly associated with IPI, but not with MTVs and TLGs. Univariate factors predicting OS3 were XL MTV (hazard ratio [HR] = 1.29), BMI SUVmax (HR = 0.56), and IPI (HR = 1.92). By multivariate analysis, higher IPI (HR = 2.26) and BMI SUVmax (HR = 0.91) were significant independent predictors for OS3. BMI SUVmax resulted in a negative coefficient and hence indicated a protective effect. Conclusions: Baseline 18F-FDG PET/CT MTV is significantly associated with survival. BMI identified on 18F-FDG PET/CT allows appropriate treatment that may improve survival.

Jezik:Angleški jezik
Ključne besede:bone marrow, diffuse large B-cell lymphoma, survival, 18F-FDG, PET/CT, MTV
Vrsta gradiva:Članek v reviji
Tipologija:1.01 - Izvirni znanstveni članek
Organizacija:MF - Medicinska fakulteta
FMF - Fakulteta za matematiko in fiziko
Status publikacije:Objavljeno
Različica publikacije:Objavljena publikacija
Leto izida:2024
Št. strani:17 str.
Številčenje:Vol. 16, iss. 22, art. 3762
PID:20.500.12556/RUL-176040 Povezava se odpre v novem oknu
UDK:616.4
ISSN pri članku:2072-6694
DOI:10.3390/cancers16223762 Povezava se odpre v novem oknu
COBISS.SI-ID:214486531 Povezava se odpre v novem oknu
Datum objave v RUL:19.11.2025
Število ogledov:342
Število prenosov:198
Metapodatki:XML DC-XML DC-RDF
:
Kopiraj citat
Objavi na:Bookmark and Share

Gradivo je del revije

Naslov:Cancers
Skrajšan naslov:Cancers
Založnik:MDPI
ISSN:2072-6694
COBISS.SI-ID:517914137 Povezava se odpre v novem oknu

Licence

Licenca:CC BY 4.0, Creative Commons Priznanje avtorstva 4.0 Mednarodna
Povezava:http://creativecommons.org/licenses/by/4.0/deed.sl
Opis:To je standardna licenca Creative Commons, ki daje uporabnikom največ možnosti za nadaljnjo uporabo dela, pri čemer morajo navesti avtorja.

Sekundarni jezik

Jezik:Slovenski jezik
Ključne besede:kostni mozeg, difuzni velikocelični limfom B, preživetje

Projekti

Financer:ARRS - Agencija za raziskovalno dejavnost Republike Slovenije
Številka projekta:P3-0321
Naslov:Napovedni dejavniki poteka bolezni in odgovora na zdravljenje pri različnih vrstah raka

Financer:ARRS - Agencija za raziskovalno dejavnost Republike Slovenije
Številka projekta:P1-0389
Naslov:Medicinska fizika

Podobna dela

Podobna dela v RUL:
Podobna dela v drugih slovenskih zbirkah:

Nazaj